Trial of Cognitive Behavioral Therapy for Schizophrenia
Phase 3 Randomized Controlled Trial of Cognitive Behavioural Therapy for Patients With Schizophrenia
1 other identifier
interventional
70
1 country
1
Brief Summary
The following study addresses the hypothesis that cognitive-behavioral interventions will be effective in reducing positive and negative symptoms of schizophrenia under the conditions of the German health care system. It is also hypothesized that interventions designed to reduce delusions will reduce cognitive biases and dysfunctional self-concepts.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for phase_3 schizophrenia
Started Mar 2006
Longer than P75 for phase_3 schizophrenia
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2006
CompletedFirst Submitted
Initial submission to the registry
March 8, 2006
CompletedFirst Posted
Study publicly available on registry
March 9, 2006
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2009
CompletedMarch 9, 2006
March 1, 2006
March 8, 2006
March 8, 2006
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Positive and Negative Syndrome Scale (PANSS)before and after treatment and at 1-year-follow-up
Secondary Outcomes (3)
Depression before and after treatment and at 1-year-follow-up
Dysfunctional Attitudes before and after treatment and at 1-year-follow-up
Cognitive biases (jumping to conclusions, attribution, theory of mind) before and after treatment
Interventions
Eligibility Criteria
You may qualify if:
- persons with a primary diagnosis of schizophrenia, schizoaffective disorder, delusional disorder acute or in incomplete remission a value of at least 3 on delusions, P1, P3 or G9 in Positive and Negative Syndrome Scale
- fluent in German language
You may not qualify if:
- severe organic brain disease
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Philipps-Universität
Marburg, 35032, Germany
Related Links
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Tania M Lincoln, PhD
Philipps-Universität Marburg, Faculty of Psychology, Section for Clinical Psychology and Psychotherapy
- STUDY DIRECTOR
Tania M Lincoln, PhD
Philipps-Universität Marburg, Faculty of Psychology, Section for Clinical Psychology and Psychotherapy
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- phase 3
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Purpose
- TREATMENT
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
March 8, 2006
First Posted
March 9, 2006
Study Start
March 1, 2006
Study Completion
August 1, 2009
Last Updated
March 9, 2006
Record last verified: 2006-03